XML 20 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated income statements - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Consolidated income statements [Abstract]      
Revenue $ 1,013,260 $ 1,011,452 $ 1,043,822
Other operating income 99,525 93,774 132,557
Employee benefit expenses (54,464) (32,246) (15,130)
Depreciation, amortization, and impairment charges (408,604) (310,755) (362,697)
Other operating expenses (276,666) (261,776) (310,642)
Operating profit 373,051 500,449 487,910
Financial income 7,052 4,121 36,444
Financial expense (378,386) (407,990) (425,019)
Net exchange differences (1,351) 2,674 1,597
Other financial income/(expense), net 40,875 (1,153) (8,235)
Financial expense, net (331,810) (402,348) (395,213)
Share of profit of associates carried under the equity method 510 7,457 5,231
Profit before income tax 41,751 105,558 97,928
Income tax expense (24,877) (30,950) (42,659)
Profit for the period 16,874 74,608 55,269
Profit attributable to non-controlling interests (4,906) (12,473) (13,673)
Profit for the period attributable to the Company $ 11,968 $ 62,135 $ 41,596
Weighted average number of ordinary shares outstanding (in shares) - basic 101,879 101,063 100,217
Weighted average number of ordinary shares outstanding (in shares) - diluted 103,392 101,063 100,217
Basic earnings per share (in dollars per share) $ 0.12 $ 0.61 $ 0.42
Diluted earnings per share (in dollars per share) $ 0.12 $ 0.61 $ 0.42